Application of PA-ETCO2 in patients with mechanical ventilation and its relationship with respiratory mechanical parameters

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046259

Enrollment

Unknown

Registered

2021-05-12

Start date

2022-01-01

Completion date

Unknown

Last updated

2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical ventilation for severe pulmonary diseases

Interventions

Severe pneumonia group:Nil

Multiple trauma group:Nil

Chronic obstructive pulmonary disease group:Nil

Severe cerebrovascular disease group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with mechanical ventilation (otracheal intubation or tracheotomy) were admitted to our department from January 2022 to December 2022; 2. Continuous use of ventilator assisted breathing, stable hemodynamics, no application of vasoactive drugs or small doses of vasoactive drugs (less than 5µg/ (kg.min) of dopamine); 3. Informed consent should be obtained from the subjects' family members, and informed consent should be signed.

Exclusion criteria

Exclusion criteria: Patients with serious heart, liver and kidney dysfunction.

Design outcomes

Primary

Measure	Time frame
Arterial blood-end-expiratory carbon dioxide partial pressure difference;Arterial partial pressure of carbon dioxide;Static compliance;Platform compression;Airway resistance;Driving pressure;	—

Secondary

Measure	Time frame
Oxygenation Index;Arterial partial pressure of oxygen;	—

Countries

China

Contacts

Public ContactZheng Aihua

Chongqing Shapingba District People's Hospital

3470189716@qq.com+86 13667628482

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026